George Ansstas
Washington University in St. Louis(US)Saint Louis University(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, CAR-T cell therapy research
Most-Cited Works
- → Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study(2024)640 cited
- → Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter(2022)467 cited
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)373 cited
- → Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy(2016)291 cited
- → Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4(2011)174 cited
- → Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations(2022)95 cited
- → Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors(2019)76 cited
- → The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions(2020)68 cited
- → Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201/KEYNOTE-942 trial.(2023)65 cited
- → Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF -Mutated High-Grade Glioma(2018)60 cited